Robyn S Lee1,2, Anders Gonçalves da Silva1, Sarah L Baines3, Janet Strachan1, Susan Ballard1, Glen P Carter1, Jason C Kwong3, Mark B Schultz1, Dieter M Bulach1, Torsten Seemann4, Timothy P Stinear3, Benjamin P Howden1,5. 1. The Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Level 1, Melbourne, Victoria, Australia. 2. Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, 677 Huntington Avenue, Level 5, Boston, MA, USA. 3. Department of Microbiology and Immunology, The University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Level 1, Melbourne, Victoria, Australia. 4. Melbourne Bioinformatics Group, Lab-14, 700 Swanston Street, Carlton, Victoria, Australia. 5. Infectious Diseases Department, Austin Health, Studley Rd, Heidelberg, Victoria, Australia.
Abstract
Background: Vancomycin-resistant Enterococcus faecium (VREfm) represent a major source of nosocomial infection worldwide. In Australia, there has been a recent concerning increase in bacteraemia associated with the vanA genotype, prompting investigation into the genomic epidemiology of VREfm. Methods: A population-level study of VREfm (10 November-9 December 2015) was conducted. A total of 321 VREfm isolates (from 286 patients) across Victoria State were collected and sequenced with Illumina NextSeq. SNPs were used to assess relatedness. STs and genes associated with resistance and virulence were identified. The vanA-harbouring plasmid from an isolate from each ST was assembled using long-read data. Illumina reads from remaining isolates were then mapped to these assemblies to identify their probable vanA-harbouring plasmid. Results: vanA-VREfm comprised 17.8% of isolates. ST203, ST80 and a pstS(-) clade, ST1421, predominated (30.5%, 30.5% and 37.2%, respectively). Most vanB-VREfm were ST796 (77.7%). vanA-VREfm were more closely related within hospitals versus between them [core SNPs 10 (IQR 1-357) versus 356 (179-416), respectively], suggesting discrete introductions of vanA-VREfm, with subsequent intra-hospital transmission. In contrast, vanB-VREfm had similar core SNP distributions within versus between hospitals, due to widespread dissemination of ST796. Different vanA-harbouring plasmids were found across STs. With the exception of ST78 and ST796, Tn1546 transposons also varied. Phylogenetic analysis revealed Australian strains were often interspersed with those from other countries, suggesting ongoing cross-continental transmission. Conclusions: Emerging vanA-VREfm in Australia is polyclonal, indicating repeat introductions of vanA-VREfm into hospitals and subsequent dissemination. The close relationship to global strains reinforces the need for ongoing screening and control of VREfm in Australia and abroad.
Background: Vancomycin-resistant Enterococcus faecium (VREfm) represent a major source of nosocomial infection worldwide. In Australia, there has been a recent concerning increase in bacteraemia associated with the vanA genotype, prompting investigation into the genomic epidemiology of VREfm. Methods: A population-level study of VREfm (10 November-9 December 2015) was conducted. A total of 321 VREfm isolates (from 286 patients) across Victoria State were collected and sequenced with Illumina NextSeq. SNPs were used to assess relatedness. STs and genes associated with resistance and virulence were identified. The vanA-harbouring plasmid from an isolate from each ST was assembled using long-read data. Illumina reads from remaining isolates were then mapped to these assemblies to identify their probable vanA-harbouring plasmid. Results:vanA-VREfm comprised 17.8% of isolates. ST203, ST80 and a pstS(-) clade, ST1421, predominated (30.5%, 30.5% and 37.2%, respectively). Most vanB-VREfm were ST796 (77.7%). vanA-VREfm were more closely related within hospitals versus between them [core SNPs 10 (IQR 1-357) versus 356 (179-416), respectively], suggesting discrete introductions of vanA-VREfm, with subsequent intra-hospital transmission. In contrast, vanB-VREfm had similar core SNP distributions within versus between hospitals, due to widespread dissemination of ST796. Different vanA-harbouring plasmids were found across STs. With the exception of ST78 and ST796, Tn1546 transposons also varied. Phylogenetic analysis revealed Australian strains were often interspersed with those from other countries, suggesting ongoing cross-continental transmission. Conclusions: Emerging vanA-VREfm in Australia is polyclonal, indicating repeat introductions of vanA-VREfm into hospitals and subsequent dissemination. The close relationship to global strains reinforces the need for ongoing screening and control of VREfm in Australia and abroad.
Authors: Leonardos Mageiros; Guillaume Méric; Sion C Bayliss; Johan Pensar; Ben Pascoe; Evangelos Mourkas; Jessica K Calland; Koji Yahara; Susan Murray; Thomas S Wilkinson; Lisa K Williams; Matthew D Hitchings; Jonathan Porter; Kirsty Kemmett; Edward J Feil; Keith A Jolley; Nicola J Williams; Jukka Corander; Samuel K Sheppard Journal: Nat Commun Date: 2021-02-03 Impact factor: 14.919
Authors: Jane Hawkey; Kelly L Wyres; Louise M Judd; Taylor Harshegyi; Luke Blakeway; Ryan R Wick; Adam W J Jenney; Kathryn E Holt Journal: Genome Med Date: 2022-08-23 Impact factor: 15.266
Authors: Lindsay A Rogers; Kayla Strong; Susan C Cork; Tim A McAllister; Karen Liljebjelke; Rahat Zaheer; Sylvia L Checkley Journal: Front Public Health Date: 2021-06-10
Authors: Anuradha Ravi; Fenella D Halstead; Amy Bamford; Anna Casey; Nicholas M Thomson; Willem van Schaik; Catherine Snelson; Robert Goulden; Ebenezer Foster-Nyarko; George M Savva; Tony Whitehouse; Mark J Pallen; Beryl A Oppenheim Journal: Microb Genom Date: 2019-09-11
Authors: Sergio Arredondo-Alonso; Janetta Top; Jukka Corander; Rob J L Willems; Anita C Schürch Journal: Genome Med Date: 2021-01-20 Impact factor: 11.117